---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-208710"
form_type: "8-K"
ticker: "TEVA"
cik: "0000818686"
company_name: "TEVA PHARMACEUTICAL INDUSTRIES LTD"
filed_at: "2021-07-06T23:59:59+00:00"
generated_at: "2026-06-30T07:23:28.411585+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Director Abbas Hussain resigns from Teva board effective July 6, 2021

## Summary
- Abbas Hussain resigned from Teva's Board effective July 6, 2021.
- He served as a director since September 2020 and was on Audit, Finance and Investment, and Science and Technology committees.
- Resignation due to his new role as CEO of Vifor Pharma Group, not due to any disagreements with Teva.

## SEC filing metadata
- accession: 0001193125-21-208710
- form_type: 8-K
- ticker: TEVA
- cik: 0000818686
- company_name: TEVA PHARMACEUTICAL INDUSTRIES LTD
- filed_at: 2021-07-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/818686/000119312521208710/0001193125-21-208710-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/818686/000119312521208710/d111873d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-208710
- JSON: https://secwatch.observer/filing/0001193125-21-208710.json
- Plain text: https://secwatch.observer/filing/0001193125-21-208710.txt

## Key facts
- Executive change
  Abbas Hussain resigned as Director at TEVA PHARMACEUTICAL INDUSTRIES LTD.
  - Action: resigned
  - Role: Director
  source text: On July 2, 2021, Abbas Hussain informed Teva Pharmaceutical Industries Limited (“Teva”) that, in light of his new role and increased responsibilities as Chief Executive Officer of Vifor Pharma Group, he would resign from Teva’s Board of Directors, effective as of July 6, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/818686/000119312521208710/0001193125-21-208710-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.